These obese patients show an association with a non-eosinophilic phenotype that is characterized by late-onset asthma in middle-aged females with high expression of symptoms [12] and who may have some resistance to current therapeutics, including steroid resistance [13], tend to have poorer asthma control and higher risk of exacerbation [14]
It is important that future studies include those with severe alcohol use disorder, including those who are treatment seeking and who may desire abstinence. Finally, Lief Fenno, MD, PhD, chair of the American Psychiatric Associations Council on Addiction Psychiatry and assistant professor of psychiatry at UT Austin Dell Medical School in Texas explained that: There have been rumors that GLP1s may have an effect on alcohol consumption we need high quality studies with direct clinical utility to know whether the rumors are true, and if so, how to use this class of medications effectively and with which patients
People get on these medications, and theres no plan where you reach a goal and come off
For a lot of people new to peptide therapy, that points toward semaglutide a gentler, well-established starting point
It is thought that around 25% to 33% of the total body weight lost is from lean muscle mass
Importantly, estrogen and hormone therapy are not prescribed as fat loss drugs